Two alternative explanations can be contemplated to interpret the close association existing between the LMO2 oncogene and human T‐ALL development: on the one side, the classical interpretation that considers that the role of LMO2 as the T‐ALL‐initiating genetic alteration takes place in a committed/differentiated target T cell. Here, LMO2 is linked to acute lymphoblastic leukemia.